10 20 30 40 50 60 70 80 1FDW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER DEHYDROGENASE 16-JAN-98 1FDW
TITLE HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221Q TITLE 2 COMPLEXED WITH ESTRADIOL
COMPND MOL_ID: 1; COMPND 2 MOLECULE: 17-BETA-HYDROXYSTEROID DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.62; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: CYTOPLASM; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PVL1393
KEYWDS DEHYDROGENASE, 17-BETA-HYDROXYSTEROID, MUTANT, ESTRADIOL, NADP
EXPDTA X-RAY DIFFRACTION
AUTHOR C.MAZZA,R.BRETON,D.HOUSSET,J.-C.FONTECILLA-CAMPS
REVDAT 3 13-JUL-11 1FDW 1 VERSN REVDAT 2 24-FEB-09 1FDW 1 VERSN REVDAT 1 27-MAY-98 1FDW 0
JRNL AUTH C.MAZZA,R.BRETON,D.HOUSSET,J.C.FONTECILLA-CAMPS JRNL TITL UNUSUAL CHARGE STABILIZATION OF NADP+ IN JRNL TITL 2 17BETA-HYDROXYSTEROID DEHYDROGENASE. JRNL REF J.BIOL.CHEM. V. 273 8145 1998 JRNL REFN ISSN 0021-9258 JRNL PMID 9525918 JRNL DOI 10.1074/JBC.273.14.8145
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.MAZZA REMARK 1 TITL HUMAN TYPE I 17BETA-HYDROXYSTEROID DEHYDROGENASE: SITE REMARK 1 TITL 2 DIRECTED MUTAGENESIS AND X-RAY CRYSTALLOGRAPHY REMARK 1 TITL 3 STRUCTURE-FUNCTION ANALYSIS REMARK 1 REF THESIS, UNIVERSITE JOSEPH 1997 REMARK 1 REF 2 FOURIER REMARK 1 PUBL GRENOBLE : UNIVERSITE JOSEPH FOURIER (THESIS) REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH R.BRETON,D.HOUSSET,C.MAZZA,J.C.FONTECILLA-CAMPS REMARK 1 TITL THE STRUCTURE OF A COMPLEX OF HUMAN 17BETA-HYDROXYSTEROID REMARK 1 TITL 2 DEHYDROGENASE WITH ESTRADIOL AND NADP+ IDENTIFIES TWO REMARK 1 TITL 3 PRINCIPAL TARGETS FOR THE DESIGN OF INHIBITORS REMARK 1 REF STRUCTURE V. 4 905 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.GHOSH,V.Z.PLETNEV,D.W.ZHU,Z.WAWRZAK,W.L.DUAX,W.PANGBORN, REMARK 1 AUTH 2 F.LABRIE,S.X.LIN REMARK 1 TITL STRUCTURE OF HUMAN ESTROGENIC 17 BETA-HYDROXYSTEROID REMARK 1 TITL 2 DEHYDROGENASE AT 2.20 A RESOLUTION REMARK 1 REF STRUCTURE V. 3 503 1995 REMARK 1 REFN ISSN 0969-2126
REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 4887 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 229 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2128 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.012 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.031 ; 0.030 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.046 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.013 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.178 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.417 ; 0.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 0.768 ; 1.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 0.684 ; 0.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.140 ; 1.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE LOOP 191 - 197 HAS BEEN EXCLUDED REMARK 3 FROM THE COORDINATE FILE.
REMARK 4 REMARK 4 1FDW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-94 REMARK 200 TEMPERATURE (KELVIN) : 300 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS-NICOLET X100 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6352 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 35.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 65.2 REMARK 200 DATA REDUNDANCY : 2.540 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FDT REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM PEG 4000 REMARK 280 30%, 100 MM HEPES BUFFER PH 7.0, 100 MM MGCL2, 0.5 MM ESTRADIOL, REMARK 280 PROPANE DIOL 2-4%
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.83500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.74500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.83500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.74500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 114.86913 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 60.99837
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 192 REMARK 465 MET A 193 REMARK 465 GLU A 194 REMARK 465 LYS A 195 REMARK 465 VAL A 196 REMARK 465 LEU A 197 REMARK 465 ASP A 286 REMARK 465 VAL A 287 REMARK 465 PRO A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 ALA A 293 REMARK 465 GLY A 294 REMARK 465 ALA A 295 REMARK 465 GLU A 296 REMARK 465 ALA A 297 REMARK 465 GLY A 298 REMARK 465 GLY A 299 REMARK 465 GLY A 300 REMARK 465 ARG A 301 REMARK 465 GLY A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 ALA A 305 REMARK 465 GLU A 306 REMARK 465 ASP A 307 REMARK 465 GLU A 308 REMARK 465 ALA A 309 REMARK 465 GLY A 310 REMARK 465 ARG A 311 REMARK 465 SER A 312 REMARK 465 ALA A 313 REMARK 465 VAL A 314 REMARK 465 GLY A 315 REMARK 465 ASP A 316 REMARK 465 PRO A 317 REMARK 465 GLU A 318 REMARK 465 LEU A 319 REMARK 465 GLY A 320 REMARK 465 ASP A 321 REMARK 465 PRO A 322 REMARK 465 PRO A 323 REMARK 465 ALA A 324 REMARK 465 ALA A 325 REMARK 465 PRO A 326 REMARK 465 GLN A 327
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 21 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP A 38 CB - CG - OD1 ANGL. DEV. = -6.9 DEGREES REMARK 500 ARG A 44 CD - NE - CZ ANGL. DEV. = 15.7 DEGREES REMARK 500 ARG A 44 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 67 CD - NE - CZ ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG A 67 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG A 258 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 2 -86.10 -71.79 REMARK 500 THR A 3 107.07 -49.11 REMARK 500 SER A 12 -163.20 176.53 REMARK 500 SER A 24 32.21 -88.68 REMARK 500 LYS A 40 24.53 -72.71 REMARK 500 GLU A 81 -7.98 -55.06 REMARK 500 VAL A 115 -75.02 -81.61 REMARK 500 SER A 134 149.88 -170.52 REMARK 500 PHE A 151 -1.81 70.84 REMARK 500 LEU A 174 -80.37 -26.99 REMARK 500 ARG A 206 50.70 -97.45 REMARK 500 ILE A 209 -31.95 -36.41 REMARK 500 ARG A 227 -39.79 -36.02 REMARK 500 MET A 265 1.51 -68.11 REMARK 500 SER A 273 -15.81 -48.96 REMARK 500 PHE A 284 -110.58 -78.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LEU A 260 23.8 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST A 350
DBREF 1FDW A 1 327 UNP P14061 DHB1_HUMAN 1 327
SEQADV 1FDW GLN A 221 UNP P14061 HIS 221 ENGINEERED SEQADV 1FDW ARG A 301 UNP P14061 ALA 301 CONFLICT
SEQRES 1 A 327 ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER GLY SEQRES 2 A 327 ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP PRO SEQRES 3 A 327 SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP LEU SEQRES 4 A 327 LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA LEU SEQRES 5 A 327 ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU ASP SEQRES 6 A 327 VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU ARG SEQRES 7 A 327 VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN ALA SEQRES 8 A 327 GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY GLU SEQRES 9 A 327 ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL GLY SEQRES 10 A 327 THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET LYS SEQRES 11 A 327 ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER VAL SEQRES 12 A 327 GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR CYS SEQRES 13 A 327 ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER LEU SEQRES 14 A 327 ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER LEU SEQRES 15 A 327 ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU LYS SEQRES 16 A 327 VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR ASP SEQRES 17 A 327 ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA GLN SEQRES 18 A 327 SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO GLU SEQRES 19 A 327 GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA PRO SEQRES 20 A 327 LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE LEU SEQRES 21 A 327 PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SER SEQRES 22 A 327 ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY ASP SEQRES 23 A 327 VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY GLY SEQRES 24 A 327 GLY ARG GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SER SEQRES 25 A 327 ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA ALA SEQRES 26 A 327 PRO GLN
HET EST A 350 20
HETNAM EST ESTRADIOL
FORMUL 2 EST C18 H24 O2 FORMUL 3 HOH *8(H2 O)
HELIX 1 1 GLY A 13 ALA A 23 1 11 HELIX 2 2 LEU A 39 ALA A 51 5 13 HELIX 3 3 SER A 69 ARG A 78 1 10 HELIX 4 4 LEU A 99 ALA A 101 5 3 HELIX 5 5 GLU A 104 ASN A 114 1 11 HELIX 6 6 VAL A 116 ARG A 132 1 17 HELIX 7 7 VAL A 143 GLY A 145 5 3 HELIX 8 8 ASP A 153 PHE A 176 1 24 HELIX 9 9 PRO A 200 ASP A 205 1 6 HELIX 10 10 ILE A 209 ALA A 229 1 21 HELIX 11 11 PRO A 233 ARG A 245 1 13 HELIX 12 12 ARG A 258 ARG A 264 5 7 HELIX 13 13 SER A 273 VAL A 283 1 11
SHEET 1 A 7 ARG A 252 PHE A 254 0 SHEET 2 A 7 VAL A 178 CYS A 185 1 N LEU A 182 O TYR A 253 SHEET 3 A 7 GLY A 135 SER A 142 1 N GLY A 135 O HIS A 179 SHEET 4 A 7 VAL A 86 CYS A 89 1 N LEU A 87 O ARG A 136 SHEET 5 A 7 THR A 3 THR A 8 1 N LEU A 6 O VAL A 86 SHEET 6 A 7 PHE A 30 LEU A 36 1 N LYS A 31 O THR A 3 SHEET 7 A 7 LEU A 59 GLN A 63 1 N GLU A 60 O VAL A 32
SITE 1 CAT 3 SER A 142 TYR A 155 LYS A 159 SITE 1 AC1 8 VAL A 143 LEU A 149 GLY A 186 PRO A 187 SITE 2 AC1 8 GLN A 221 SER A 222 PHE A 259 MET A 279
CRYST1 123.670 45.490 61.630 90.00 98.21 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008086 0.000000 0.001167 0.00000
SCALE2 0.000000 0.021983 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016394 0.00000